1887
Volume 2012, Issue 1
  • ISSN: 2305-7823
  • E-ISSN:

Abstract

Abstract

Heart failure with preserved ejection fraction (HFpEF) has recently emerged as a major cause of cardiovascular morbidity and mortality. Contrary to initial beliefs, HFpEF is now known to be as common as heart failure with reduced ejection fraction (HFrEF) and carries an unacceptably high mortality rate. With a prevalence that has been steadily rising over the past two decades, it is very likely that HFpEF will represent the dominant heart failure phenotype over the coming few years. The scarcity of trials in this semi-discrete form of heart failure and lack of unified enrolment criteria in the studies conducted to date might have contributed to the current absence of specific therapies. Understanding the epidemiological, pathophysiological and molecular differences (and similarities) between these two forms of heart failure is cornerstone to the development of targeted therapies. Carefully designed studies that adhere to unified diagnostic criteria with the recruitment of appropriate controls and adoption of practical end-points are urgently needed to help identify effective treatment strategies.

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2012.10
2012-07-17
2019-08-20
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2012/1/gcsp.2012.10.html?itemId=/content/journals/10.5339/gcsp.2012.10&mimeType=html&fmt=ahah

References

  1. [1]. Bhatia   RS   et al.   Outcome of heart failure with preserved ejection fraction in a population-basedstudy. . The New England Journal of Medicine . 2006; ;355: : 260– 269 .
    [Google Scholar]
  2. [2]. Tribouilloy   C   et al.   Prognosis of heart failure with preserved ejection fraction: a 5 year prospectivepopulation-based study. . European Heart Journal . 2008; ;29: : 339– 347 .
    [Google Scholar]
  3. [3]. Hogg   K., , Swedberg   K., and McMurray   J. Heart failure with preserved left ventricular systolic function; epidemiology, clinicalcharacteristics, and prognosis. . Journal of the American College of Cardiology . 2004; ;43: : 317– 327 .
    [Google Scholar]
  4. [4]. Redfield   MM. Trends in Prevalence and Outcome of Heart Failure with Preserved EjectionFraction. . Heart Failure . 2006; ; 251– 259 .
    [Google Scholar]
  5. [5]. Paulus   WJ., and van Ballegoij   JJM. Treatment of heart failure with normal ejection fraction: an inconvenient truth!. . Journal of the American College of Cardiology . 2010; ;55: : 526– 537 .
    [Google Scholar]
  6. [6]. Holland   DJ., , Kumbhani   DJ., , Ahmed   SH., and Marwick   TH. Effects of treatment on exercise tolerance, cardiac function, and mortality in heartfailure with preserved ejection fraction. A meta-analysis. . Journal of the AmericanCollege of Cardiology . 2011; ;57: : 1676– 1686 .
    [Google Scholar]
  7. [7]. Hunt   SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronicheart failure in the adult: a report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines (Writing Committee to Updatethe 2001 Guideli. . Journal of the American College of Cardiology . 2005; ;46: : e1-82 .
    [Google Scholar]
  8. [8]. Hunt   SA   et al.   2009 focused update incorporated into the ACC/AHA 2005 Guidelines forthe Diagnosis and Management of Heart Failure in Adults: a report of theAmerican College of Cardiology Foundation/American Heart Association TaskForce on Practice Guidelines: develope. . Circulation . 2009; ;119: : e391-479 .
    [Google Scholar]
  9. [9]. Roger   VL   et al.   Heart disease and stroke statistics–2012 update: a report from the American HeartAssociation. . Circulation . 2012; ;125: : e2-e220 .
    [Google Scholar]
  10. [10]. Group   ES., and Failure   DH. Working Group Report How to diagnose diastolic heart failure. . Heart . 1998; ; 990– 1003 .
    [Google Scholar]
  11. [11]. Sanderson   JE. Heart failure with a normal ejection fraction. . Heart (British Cardiac Society) . 2007; ;93: : 155– 158 .
    [Google Scholar]
  12. [12]. McMurray   J. New Therapeutic Options in Congestive Heart Failure: Part II. . Circulation . 2002; ;105: : 2223– 2228 .
    [Google Scholar]
  13. [13]. Yu   C-M. Progression of Systolic Abnormalities in Patients With Isolated DiastolicHeart Failure and Diastolic Dysfunction. . Circulation . 2002; ;105: : 1195– 1201 .
    [Google Scholar]
  14. [14]. Baicu   CF., , Zile   MR., , Aurigemma   GP., and Gaasch   WH. Left ventricular systolic performance, function, and contractility in patients withdiastolic heart failure. . Circulation . 2005; ;111: : 2306– 2312 .
    [Google Scholar]
  15. [15]. Yip   G. Left ventricular long axis function in diastolic heart failure is reduced inboth diastole and systole: time for a redefinition?. . Heart . 2002; ;87: : 121– 125 .
    [Google Scholar]
  16. [16]. Wang   J., , Khoury   DS., , Yue   Y., , Torre-Amione   G., and Nagueh   SF. Preserved left ventricular twist and circumferential deformation, but depressedlongitudinal and radial deformation in patients with diastolic heart failure. . EuropeanHeart Journal . 2008; ;29: : 1283– 1289 .
    [Google Scholar]
  17. [17]. Petrie   MC. Diastolic heart failure or heart failure caused by subtle left ventricular systolicdysfunction?. . Heart . 2002; ;87: : 29– 31 .
    [Google Scholar]
  18. [18]. Vinereanu   D., , Nicolaides   E., , Tweddel   AC., and Fraser   AG. Pure diastolic dysfunction is associated with long-axis systolic dysfunction.Implications for the diagnosis and classification of heart failure. . European Journal ofHeart Failure . 2005; ;7: : 820– 828 .
    [Google Scholar]
  19. [19]. Davies   M   et al.   Prevalence of left-ventricular systolic dysfunction and heart failure in theEchocardiographic Heart of England Screening study: a population based study. . TheLancet . 2001; ;358: : 439– 444 .
    [Google Scholar]
  20. [20]. Petrie   M., and McMurray   J. Changes in notions about heart failure. . The Lancet . 2001; ;358: : 432– 434 .
    [Google Scholar]
  21. [21]. Hunt   SA   et al.   2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for theDiagnosis and Management of Heart Failure in Adults A Report of the AmericanCollege of Cardiology Foundation/American Heart Association Task Force onPractice Guidelines Developed. . Journal of the American College of Cardiology . 2009; ;53: : e1-e90 .
    [Google Scholar]
  22. [22]. Dickstein   K   et al.   ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2008: the Task Force for the Diagnosis and Treatment of Acute and ChronicHeart Failure 2008 of the European Society of Cardiology. Developed incollaboration with the Heart. . European heart journal . 2008; ;29: : 2388– 2442 .
    [Google Scholar]
  23. [23]. Redfield   MM. Trends in Prevalence and Outcome of Heart Failure with Preserved EjectionFraction. . Heart Failure . 2006; ; 251– 259 .
    [Google Scholar]
  24. [24]. Vasan   R., , Benjamin   E., and Levy   D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologicperspective. . J Am Coll Cardiol . 1995; ;26: : 1565– 1574 .
    [Google Scholar]
  25. [25]. Wheeldon   NM., , Clarkson   P., and Macdonald   TM. Diastolic heart failure. . Eur Heart J . 1994; ;15: : 1689– 1697 .
    [Google Scholar]
  26. [26]. Owan   TE., and Redfield   MM. Epidemiology of Diastolic Heart Failure. . Progress in Cardiovascular Diseases . 2005; ;47: : 320– 332 .
    [Google Scholar]
  27. [27]. Somaratne   JB   et al.   The prognostic significance of heart failure with preserved left ventricular ejectionfraction: a literature-based meta-analysis. . European Journal of Heart Failure . 2009; ;11: : 855– 862 .
    [Google Scholar]
  28. [28]. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) The survival ofpatients with heart failure with preserved or reduced left ventricular ejectionfraction: an individual patient data meta-analysis. European heart journalehr254- (2011). doi: 10.1093/eurheartj/ehr254.
  29. [29]. Burkhoff   D. Mortality in heart failure with preserved ejection fraction: an unacceptably highrate. . European Heart Journal . 2011; ; [CrossRef]
    https://doi.org/10.1093/eurheartj/ehr339 [Google Scholar]
  30. [30]. Cleland   J. The EuroHeart Failure survey programme—a survey on the quality of care amongpatients with heart failure in Europe Part 1: patient characteristics and diagnosis. . European Heart Journal . 2003; ;24: : 442– 463 .
    [Google Scholar]
  31. [31]. Yancy   CW., , Lopatin   M., , Stevenson   LW., , De Marco   T., and Fonarow   GC. Clinical presentation, management, and in-hospital outcomes of patients admittedwith acute decompensated heart failure with preserved systolic function:a report from the Acute Decompensated Heart Failure National Registry(ADHERE) Database. . Journal of the American College of Cardiology . 2006; ;47: : 76– 84 .
    [Google Scholar]
  32. [32]. Schulman KA and Gottdiener JS. Costs for Heart Failure WithNormal vs Reduced Ejection Fraction. 166 (2006).
  33. [33]. Aurigemma GP. Diastolic Heart Failure — A Common and Lethal Conditionby Any Name. 2005–2007 (2006).
  34. [34]. Sanderson JE, Gibson DG, Brown DJ and Goodwin JF.Left ventricular filling in hypertrophic cardiomyopathy An angiographic study’.661–670 (1977).
  35. [35]. Hanrath   P., , Mathey   DG., , Siegert   R., and Bleifeld   W. Left ventricular relaxation and filling pattern in different forms of left ventricularhypertrophy: An echocardiographic study. . The American Journal of Cardiology . 1980; ;45: : 15– 23 .
    [Google Scholar]
  36. [36]. Desk R, Williams L and Health K. Diastolic Simple Elasticand Viscoelastic Properties of the Left Ventricle in Man. 1178–1187 (1979). doi:10.1161/01.CIR.59.6.1178.
  37. [37]. Soufer   R   et al.   Intact systolic left ventricular function in clinical congestive heart failure. . TheAmerican Journal of Cardiology . 1985; ;55: : 1032– 1036 .
    [Google Scholar]
  38. [38]. Nishimura   R., and Tajik   A. Evaluation of diastolic filling of left ventricle in health and disease: Dopplerechocardiography is the clinician’s Rosetta Stone. . J Am Coll Cardiol . 1997; ;30: : 8– 18 .
    [Google Scholar]
  39. [39]. Zile MR, Baicu CF and Gaasch WH. Diastolic Heart Failure —Abnormalities in Active Relaxation and Passive Stiffness of the Left Ventricle.1953–1959 (2004).
  40. [40]. Westermann   D.   et al.   Role of left ventricular stiffness in heart failure with normal ejection fraction. . Circulation . 2008; ;117: : 2051– 260 .
    [Google Scholar]
  41. [41]. Borlaug   BA., , Nishimura   RA., , Sorajja   P., , Lam   CSP., and Redfield   MM. Exercise hemodynamics enhance diagnosis of early heart failure with preservedejection fraction. . Circulation. Heart Failure . 2010; ;3: : 588– 595 .
    [Google Scholar]
  42. [42]. Kawaguchi   M. Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failureand Preserved Ejection Fraction: Implications for Systolic and Diastolic ReserveLimitations. . Circulation . 2003; ;107: : 714– 720 .
    [Google Scholar]
  43. [43]. Frenneaux   M., and Williams   L. Ventricular-arterial and ventricular-ventricular interactions and their relevance todiastolic filling. . Progress in Cardiovascular Diseases . 2007; ;49: : 252– 262 .
    [Google Scholar]
  44. [44]. Hundley   WG   et al.   Leg flow-mediated arterial dilation in elderly patients with heart failure and normalleft ventricular ejection fraction. . American Journal of Physiology. Heart andCirculatory Physiology . 2007; ;292: : H1427-34 .
    [Google Scholar]
  45. [45]. Borlaug   Ba   et al.   Global cardiovascular reserve dysfunction in heart failure with preserved ejectionfraction. . Journal of the American College of Cardiology . 2010; ;56: : 845– 854 .
    [Google Scholar]
  46. [46]. Borlaug   B.a   et al.   Impaired chronotropic and vasodilator reserves limit exercise capacity in patientswith heart failure and a preserved ejection fraction. . Circulation . 2006; ;114: : 2138– 47 .
    [Google Scholar]
  47. [47]. Phan   TT   et al.   Heart failure with preserved ejection fraction is characterized by dynamic impairmentof active relaxation and contraction of the left ventricle on exercise and associatedwith myocardial energy deficiency. . Journal of the American College of Cardiology . 2009; ;54: : 402– 409 .
    [Google Scholar]
  48. [48]. García   EH   et al.   Reduced systolic performance by tissue Doppler in patients with preserved andabnormal ejection fraction: New insights in chronic heart failure. . InternationalJournal of Cardiology . 2006; ;108: : 181– 188 .
    [Google Scholar]
  49. [49]. Bruch   C., , Gradaus   R., , Gunia   S., , Breithardt   G., and Wichter   T. Doppler tissue analysis of mitral annular velocities: evidence for systolicabnormalities in patients with diastolic heart failure. . Journal of the American Societyof Echocardiography . 2003; ;16: : 1031– 1036 .
    [Google Scholar]
  50. [50]. Tan   YT   et al.   The pathophysiology of heart failure with normal ejection fraction: exerciseechocardiography reveals complex abnormalities of both systolic and diastolicventricular function involving torsion, untwist, and longitudinal motion. . Journal ofthe American College of Cardiology . 2009; ;54: : 36– 46 .
    [Google Scholar]
  51. [51]. Roncon-Albuquerque   R., and Leite-Moreira   AF. Cinética do cálcio na progressao da insuficiência cardíaca. . Revista portuguesa decardiologia . 23: : II.25-II.40 .
    [Google Scholar]
  52. [52]. Frank   KF., , Bölck   B., , Brixius   K., , Kranias   EG., and Schwinger   RHG. Modulation of SERCA: implications for the failing human heart. . Basic Research inCardiology . 2002; ;97: : Suppl 1 , I72-I78 .
    [Google Scholar]
  53. [53]. del Monte   F., , Harding   SE., , Dec   GW., , Gwathmey   JK., and Hajjar   RJ. Targeting phospholamban by gene transfer in human heart failure. . Circulation . 2002; ;105: : 904– 907 .
    [Google Scholar]
  54. [54]. MacLennan   DH., and Kranias   EG. Phospholamban: a crucial regulator of cardiac contractility. . Nature Reviews.Molecular Cell Biology . 2003; ;4: : 566– 77 .
    [Google Scholar]
  55. [55]. Hasenfuss   G. Calcium Cycling in Congestive Heart Failure. . Journal of Molecular and CellularCardiology . 2002; ;34: : 951– 969 .
    [Google Scholar]
  56. [56]. Ginsburg   KS., and Bers   DM. Modulation of excitation-contraction coupling by isoproterenol in cardiomyocyteswith controlled SR Ca2+ load and Ca2+ current trigger. . The Journal of Physiology . 2004; ;556: : 463– 480 .
    [Google Scholar]
  57. [57]. Li   Y., , Kranias   EG., , Mignery   GA., and Bers   DM. Protein kinase A phosphorylation of the ryanodine receptor does not affect calciumsparks in mouse ventricular myocytes. . Circulation Research . 2002; ;90: : 309– 316 .
    [Google Scholar]
  58. [58]. Lyon   AR   et al.   Loss of T-tubules and other changes to surface topography in ventricularmyocytes from failing human and rat heart. . Proceedings of the NationalAcademy of Sciences of the United States of America . 2009; ;106: : 6854– 6859 .
    [Google Scholar]
  59. [59]. Louch   WE   et al.   T-tubule disorganization and reduced synchrony of Ca2+ release in murinecardiomyocytes following myocardial infarction. . The Journal of Physiology . 2006; ;574: : 519– 533 .
    [Google Scholar]
  60. [60]. Bénitah   J-P., , Kerfant   BG., , Vassort   G., , Richard   S., and Gómez   AM. Altered communication between L-type calcium channels and ryanodine receptors inheart failure. . Frontiers in Bioscience?: a Journal and Virtual Library . 2002; ;7: : e263-75 .
    [Google Scholar]
  61. [61]. Chase   A., and Orchard   CH. Ca efflux via the sarcolemmal Ca ATPase occurs only in the t-tubules of ratventricular myocytes. . Journal of Molecular and Cellular Cardiology . 2011; ;50: : 187– 193 .
    [Google Scholar]
  62. [62]. Ibrahim   M., , Gorelik   J., , Yacoub   MH., and Terracciano   CM. The structure and function of cardiac t-tubules in health and disease. . Proceedings.Biological Sciences/The Royal Society . 2011; ;278: : 2714– 223 .
    [Google Scholar]
  63. [63]. Wei   S   et al.   T-tubule remodeling during transition from hypertrophy to heart failure. . CirculationResearch . 2010; ;107: : 520– 531 .
    [Google Scholar]
  64. [64]. Paulus   WJ., , Bronzwaer   JG., , Felice   H., , Kishan   N., and Wellens   F. Deficient acceleration of left ventricular relaxation during exercise after hearttransplantation. . Circulation . 1992; ;86: : 1175– 1185 .
    [Google Scholar]
  65. [65]. Leite-Moreira   AF., and Gillebert   TC. Nonuniform course of left ventricular pressure fall and its regulation by load andcontractile state. . Circulation . 1994; ;90: : 2481– 2491 .
    [Google Scholar]
  66. [66]. Leite-Moreira   A. Afterload induced changes in myocardial relaxation A mechanism for diastolicdysfunction. . Cardiovascular Research . 1999; ;43: : 344– 353 .
    [Google Scholar]
  67. [67]. Wu   Y. Changes in Titin and Collagen Underlie Diastolic Stiffness Diversity of CardiacMuscle. . Journal of Molecular and Cellular Cardiology . 2000; ;32: : 2151– 2162 .
    [Google Scholar]
  68. [68]. Lim   CC. Modulation of Cardiac Function: Titin Springs into Action. . The Journal of GeneralPhysiology . 2005; ;125: : 249– 252 .
    [Google Scholar]
  69. [69]. Fukuda   N. Phosphorylation of Titin Modulates Passive Stiffness of Cardiac Muscle in a TitinIsoform-dependent Manner. . The Journal of General Physiology . 2005; ;125: : 257– 271 .
    [Google Scholar]
  70. [70]. Yamamoto   K. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatoryor excessive hypertrophy in hypertensive heart. . Cardiovascular Research . 2002; ;55: : 76– 82 .
    [Google Scholar]
  71. [71]. Neagoe   C. Titin Isoform Switch in Ischemic Human Heart Disease. . Circulation . 2002; ;106: : 1333– 1341 .
    [Google Scholar]
  72. [72]. Guo   W   et al.   RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. . NatureMedicine . 2012; ; [CrossRef]
    https://doi.org/10.1038/nm.2693 [Google Scholar]
  73. [73]. Linke   Wa., and Bücker   S. King of hearts: a splicing factor rules cardiac proteins. . Nature Medicine . 2012; ;18: : 660– 661 .
    [Google Scholar]
  74. [74]. Kato   S   et al.   Inhibition of collagen cross-linking: effects on fibrillar collagen and ventriculardiastolic function. . Am J Physiol Heart Circ Physiol . 1995; ;269: : H863-868 .
    [Google Scholar]
  75. [75]. Ahmed   SH   et al.   Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationshipbetween changes in proteolytic determinants of matrix composition and structural,functional, and clinical manifestations of hypertensive heart disease. . Circulation . 2006; ;113: : 2089– 2096 .
    [Google Scholar]
  76. [76]. Heymans   S.. Increased Cardiac Expression of Tissue Inhibitor of Metalloproteinase-1 and TissueInhibitor of Metalloproteinase-2 Is Related to Cardiac Fibrosis and Dysfunction inthe Chronic Pressure-Overloaded Human Heart. . Circulation . 2005; ;112: : 1136– 1144 .
    [Google Scholar]
  77. [77]. Gonzalez   A   et al.   Filling Pressures and Collagen Metabolism in Hypertensive Patients WithHeart Failure and Normal Ejection Fraction. . Hypertension . 2010; ;55: : 1418– 1424 .
    [Google Scholar]
  78. [78]. Hitch   DC., and Nolan   SP. Descriptive analysis of instantaneous left atrial volume—with special reference to leftatrial function. . Journal of Surgical Research . 1981; ;30: : 110– 120 .
    [Google Scholar]
  79. [79]. Prioli   A., , Marino   P., , Lanzoni   L., and Zardini   P. Increasing degrees of left ventricular filling impairment modulate left atrialfunction in humans. . The American Journal of Cardiology . 1998; ;82: : 756– 761 .
    [Google Scholar]
  80. [80]. Stefanadis   C., , Dernellis   J., and Toutouzas   P. Evaluation of the Left Atrial Performance Using Acoustic Quantification. . Echocardiography (Mount Kisco, N.Y.) . 1999; ;16: : 117– 125 .
    [Google Scholar]
  81. [81]. Bowman   AW., and Kovács   SJ. Left atrial conduit volume is generated by deviation from the constant-volumestate of the left heart: a combined MRI-echocardiographic study. . AmericanJournal of Physiology. Heart and Circulatory Physiology . 2004; ;286: : H2416-24 .
    [Google Scholar]
  82. [82]. Kurt   M., , Wang   J., , Torre-Amione   G., and Nagueh   SF. Left atrial function in diastolic heart failure. . Circulation. Cardiovascular Imaging . 2009; ;2: : 10-5 .
    [Google Scholar]
  83. [83]. Lester   SJ   et al.   Unlocking the Mysteries of Diastolic Function. . Journal of the American College ofCardiology . 2010; ; [CrossRef]
    https://doi.org/10.1016/j.jacc.2007.09.061 [Google Scholar]
  84. [84]. Kuznetsova   T   et al.   Prevalence of left ventricular diastolic dysfunction in a general population. . Circulation. Heart Failure . 2009; ;2: : 105– 112 .
    [Google Scholar]
  85. [85]. Redfield   MM   et al.   Burden of systolic and diastolic ventricular dysfunction in the community:appreciating the scope of the heart failure epidemic. . JAMA: the Journal of theAmerican Medical Association . 2003; ;289: : 194– 202 .
    [Google Scholar]
  86. [86]. Melenovsky   V   et al.   Cardiovascular features of heart failure with preserved ejection fraction versusnonfailing hypertensive left ventricular hypertrophy in the urban Baltimorecommunity: the role of atrial remodeling/dysfunction. . Journal of the AmericanCollege of Cardiology . 2007; ;49: : 198– 207 .
    [Google Scholar]
  87. [87]. Hundley   WG   et al.   Cardiac cycle-dependent changes in aortic area and distensibility are reduced inolder patients with isolated diastolic heart failure and correlate with exerciseintolerance. . Journal of the American College of Cardiology . 2001; ;38: : 796– 802 .
    [Google Scholar]
  88. [88]. Borlaug   BA., and Kass   DA. Ventricular-vascular interaction in heart failure. . Heart Failure Clinics . 2008; ;4: : 23– 36 .
    [Google Scholar]
  89. [89]. Dauterman   K   et al.   Contribution of external forces to left ventricular diastolic pressure. Implications forthe clinical use of the Starling law. . Annals of Internal Medicine . 1995; ;122: : 737– 742 .
    [Google Scholar]
  90. [90]. Yacoub   MH. Two hearts that beat as one. . Circulation . 1995; ;92: : 156– 157 .
    [Google Scholar]
  91. [91]. Lam   CSP   et al.   Pulmonary hypertension in heart failure with preserved ejection fraction: acommunity-based study. . Journal of the American College of Cardiology . 2009; ;53: : 1119– 1126 .
    [Google Scholar]
  92. [92]. Ennezat   PV   et al.   Left ventricular abnormal response during dynamic exercise in patients with heartfailure and preserved left ventricular ejection fraction at rest. . Journal of CardiacFailure . 2008; ;14: : 475– 480 .
    [Google Scholar]
  93. [93]. Haykowsky   MJ   et al.   Determinants of exercise intolerance in elderly heart failure patients with preservedejection fraction. . Journal of the American College of Cardiology . 2011; ;58: : 265– 274 .
    [Google Scholar]
  94. [94]. Brubaker   PH   et al.   Chronotropic incompetence and its contribution to exercise intolerance in olderheart failure patients. . Journal of Cardiopulmonary Rehabilitation . 26: : 86– 89 .
    [Google Scholar]
  95. [95]. Nikitin   NP., , Witte   KK., , Clark   AL., and Cleland   JG. Color tissue Doppler-derived long-axis left ventricular function in heart failure withpreserved global systolic function. . The American Journal of Cardiology . 2002; ;90: : 1174– 1177 .
    [Google Scholar]
  96. [96]. Wang   J., , Kurrelmeyer   KM., , Torre-amione   G., , Sherif   F., and Nagueh   SF. and the Effect of Medical Therapy Systolic and Diastolic Dyssynchrony inPatients With Diastolic Heart Failure and the Effect of Medical Therapy. . Journal of the American College of Cardiology . 2010; ; [CrossRef]
    https://doi.org/10.1016/j.jacc.2006.10.023 [Google Scholar]
  97. [97]. Lee   AP-W   et al.   LV mechanical dyssynchrony in heart failure with preserved ejection fractioncomplicating acute coronary syndrome. . JACC. Cardiovascular Imaging . 2011; ;4: : 348– 357 .
    [Google Scholar]
  98. [98]. Sanderson   JE. Systolic and diastolic ventricular dyssynchrony in systolic and diastolicheart failure. . Journal of the American College of Cardiology . 2007; ;49: : 106– 108 .
    [Google Scholar]
  99. [99]. Sengupta   PP   et al.   Focus issue?: Cardiac imaging left ventricular structure and function. . Journal of theAmerican College of Cardiology . 2010; ; [CrossRef]
    https://doi.org/10.1016/j.jacc.2006.08.030 [Google Scholar]
  100. [100]. Baicu   CF., , Zile   MR., , Aurigemma   GP., and Gaasch   WH. Left ventricular systolic performance, function, and contractility in patients withdiastolic heart failure. . Circulation . 2005; ;111: : 2306– 2312 .
    [Google Scholar]
  101. [101]. Willenheimer   R   et al.   Left atrioventricular plane displacement is related to both systolic and diastolic leftventricular performance in patients with chronic heart failure. . Heart . 1999; ; 612– 618 .
    [Google Scholar]
  102. [102]. Vasan   RS., and Levy   D. Defining diastolic heart failure: a call for standardized diagnostic criteria. . Circulation . 2000; ;101: : 2118– 2121 .
    [Google Scholar]
  103. [103]. Yturralde   RF., and Gaasch   WH. Diagnostic criteria for diastolic heart failure. . Progress in Cardiovascular Diseases . 47: : 314– 319 .
    [Google Scholar]
  104. [104]. Paulus   WJ   et al.   How to diagnose diastolic heart failure: a consensus statement on the diagnosis ofheart failure with normal left ventricular ejection fraction by the Heart Failure andEchocardiography Associations of the European Society of Cardiology. . EuropeanHeart Journal . 2007; ;28: : 2539– 2550 .
    [Google Scholar]
  105. [105]. Galiè   N   et al.   Guidelines for the diagnosis and treatment of pulmonary hypertension: The TaskForce for the Diagnosis and Treatment of Pulmonary Hypertension of theEuropean Society of Cardiology (ESC) and the European Respiratory Society(ERS), endorsed by the Internat. . European Heart Journal . 2009; ;30: : 2493– 2537 .
    [Google Scholar]
  106. [106]. Persson   H   et al.   Diastolic dysfunction in heart failure with preserved systolic function: need for objectiveevidence:results from the CHARM Echocardiographic Substudy-CHARMES. . Journalof the American College of Cardiology . 2007; ;49: : 687– 694 .
    [Google Scholar]
  107. [107]. Ommen   SR   et al.   Clinical utility of Doppler echocardiography and tissue Doppler imaging in theestimation of left ventricular filling pressures: A comparative simultaneousDoppler-catheterization study. . Circulation . 2000; ;102: : 1788– 1794 .
    [Google Scholar]
  108. [108]. Ha   J-W   et al.   Differentiation of constrictive pericarditis from restrictive cardiomyopathy usingmitral annular velocity by tissue Doppler echocardiography. . The American Journal ofCardiology . 2004; ;94: : 316– 319 .
    [Google Scholar]
  109. [109]. Kasner   M   et al.   Utility of Doppler echocardiography and tissue Doppler imaging in the estimation ofdiastolic function in heart failure with normal ejection fraction: a comparativeDoppler-conductance catheterization study. . Circulation . 2007; ;116: : 637– 647 .
    [Google Scholar]
  110. [110]. Handoko   ML., and Paulus   WJ. Polishing the diastolic dysfunction measurement stick. European journal ofechocardiography?. . Journal of the Working Group on Echocardiography of theEuropean Society of Cardiology . 2008; ;9: : 575– 577 .
    [Google Scholar]
  111. [111]. Douglas   PS. The left atrium: a biomarker of chronic diastolic dysfunction and cardiovasculardisease risk. . Journal of the American College of Cardiology . 2003; ;42: : 1206– 1207 .
    [Google Scholar]
  112. [112]. Emery   WT., , Jadavji   I., , Choy   JB., and Lawrance   RA. Investigating the European Society of Cardiology Diastology Guidelines in apractical scenario. . European Journal of Echocardiography?: the Journal of theWorking Group on Echocardiography of the European Society of Cardiology . 2008; ;9: : 685– 691 .
    [Google Scholar]
  113. [113]. Tschöpe   C   et al.   The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction:correlation with echocardiographic and invasive measurements. . European HeartJournal . 2005; ;26: : 2277– 2284 .
    [Google Scholar]
  114. [114]. Watanabe   S   et al.   Myocardial stiffness is an important determinant of the plasma brain natriureticpeptide concentration in patients with both diastolic and systolic heart failure. . European Heart Journal . 2006; ;27: : 832– 838 .
    [Google Scholar]
  115. [115]. Mottram   PM., , Leano   R., and Marwick   TH. Usefulness of B-type natriuretic peptide in hypertensive patients with exertionaldyspnea and normal left ventricular ejection fraction and correlation with newechocardiographic indexes of systolic and diastolic function. . The American Journal ofCardiology . 2003; ;92: : 1434– 1438 .
    [Google Scholar]
  116. [116]. Ambrosi   P. Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: ComparisonWith Doppler Velocity Recordings. . Circulation . 2002; ;106: : 70e-70 .
    [Google Scholar]
  117. [117]. McDonagh   TA   et al.   NT-proBNP and the diagnosis of heart failure: a pooled analysis of three Europeanepidemiological studies. . European Journal of Heart Failure . 2004; ;6: : 269– 273 .
    [Google Scholar]
  118. [118]. Jones   AE., and Kline   JA. Elevated brain natriuretic peptide in septic patients without heart failure. . Annals ofEmergency Medicine . 2003; ;42: : 714– 715 .
    [Google Scholar]
  119. [119]. La Villa   G   et al.   Plasma levels of brain natriuretic peptide in patients with cirrhosis. . Hepatology(Baltimore, Md.) . 1992; ;16: : 156– 161 .
    [Google Scholar]
  120. [120]. Forfia   PR., , Watkins   SP., , Rame   JE., , Stewart   KJ., and Shapiro   EP. Relationship between B-type natriuretic peptides and pulmonary capillary wedgepressure in the intensive care unit. . Journal of the American College of Cardiology . 2005; ;45: : 1667– 1671 .
    [Google Scholar]
  121. [121]. Tsutamoto   T   et al.   Relationship between renal function and plasma brain natriuretic peptide in patientswith heart failure. . Journal of the American College of Cardiology . 2006; ;47: : 582– 586 .
    [Google Scholar]
  122. [122]. Ando   T., , Ogawa   K., , Yamaki   K., , Hara   M., and Takagi   K. Plasma concentrations of atrial, brain, and C-type natriuretic peptides andendothelin-1 in patients with chronic respiratory diseases. . Chest . 1996; ;110: : 462– 8 .
    [Google Scholar]
  123. [123]. Tulevski   II   et al.   Increased brain natriuretic peptide as a marker for right ventricular dysfunction inacute pulmonary embolism. . Thrombosis and Haemostasis . 2001; ;86: : 1193– 1196 .
    [Google Scholar]
  124. [124]. Daniels   LB   et al.   How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis ofacute heart failure. Results from the Breathing Not Properly Multinational Study. . American Heart Journal . 2006; ;151: : 999– 1005 .
    [Google Scholar]
  125. [125]. Horwich   TB., , Hamilton   MA., and Fonarow   GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. . Journal of the American College of Cardiology . 2006; ;47: : 85– 90 .
    [Google Scholar]
  126. [126]. Maeder   MT., and Kaye   DM. Heart failure with normal leftventricular ejection fraction. . Journal of the American College of Cardiology . 2009; ;53: : 905– 918 .
    [Google Scholar]
  127. [127]. Burgess   MI., , Jenkins   C., , Sharman   JE., and Marwick   TH. Diastolic stress echocardiography: hemodynamic validation and clinical significanceof estimation of ventricular filling pressure with exercise. . Journal of the AmericanCollege of Cardiology . 2006; ;47: : 1891– 900 .
    [Google Scholar]
  128. [128]. Talreja   DR., , Nishimura   RA., and Oh   JK. Estimation of left ventricular filling pressure with exercise by Doppler echocardiographyin patients with normal systolic function: a simultaneous echocardiographic-cardiaccatheterization study. . Journal of the American Society of Echocardiography?: OfficialPublication of the American Society of Echocardiography . 2007; ;20: : 477– 479 .
    [Google Scholar]
  129. [129]. Grewal   J., , McCully   RB., , Kane   GC., , Lam   C., and Pellikka   PA. Left ventricular function and exercise capacity. . JAMA?: the journal of the AmericanMedical Association . 2009; ;301: : 286– 294 .
    [Google Scholar]
  130. [130]. Borlaug   Ba., and Paulus   WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, andtreatment. . European Heart Journal . 2011; ;32: : 670– 679 .
    [Google Scholar]
  131. [131]. Philbin   EF., , Rocco   TA., , Lindenmuth   NW., , Ulrich   K., and Jenkins   PL. Systolic versus diastolic heart failure in community practice: clinical features,outcomes, and the use of angiotensin-converting enzyme inhibitors. . The AmericanJournal of Medicine . 2000; ;109: : 605– 613 .
    [Google Scholar]
  132. [132]. Yusuf   S.   et al.   Effects of candesartan in patients with chronic heart failure and preservedleft-ventricular ejection fraction: the CHARM-Preserved Trial. . Lancet . 2003; ;362: : 777– 781 .
    [Google Scholar]
  133. [133]. Ahmed   A   et al.   Effects of digoxin on morbidity and mortality in diastolic heart failure: theancillary digitalis investigation group trial. . Circulation . 2006; ;114: : 397– 403 .
    [Google Scholar]
  134. [134]. Shah   SJ., and Gheorghiade   M. Heart Failure With Preserved Ejection Fraction . 2008; ;300: : 24– 26 .
    [Google Scholar]
  135. [135]. Ather   S.   et al.   Impact of noncardiac comorbidities on morbidity and mortality in a predominantlymale population with heart failure and preserved versus reduced ejectionfraction. . Journal of the American College of Cardiology . 2012; ;59: : 998– 1005 .
    [Google Scholar]
  136. [136]. Gary   RA   et al.   Home-based exercise improves functional performance and quality of life in womenwith diastolic heart failure. . Heart & Lung: The Journal of Acute and Critical Care . 2004; ;33: : 210– 218 .
    [Google Scholar]
  137. [137]. Nodari   S., , Metra   M., and Dei Cas   L. Beta-blocker treatment of patients with diastolic heart failure and arterialhypertension. A prospective, randomized, comparison of the long-term effects ofatenolol vs. nebivolol. . European Journal of Heart Failure . 2003; ;5: : 621– 627 .
    [Google Scholar]
  138. [138]. Flather   MD   et al.   Randomized trial to determine the effect of nebivolol on mortality and cardiovascularhospital admission in elderly patients with heart failure (SENIORS). . European HeartJournal . 2005; ;26: : 215– 225 .
    [Google Scholar]
  139. [139]. Bergström   A   et al.   Effect of carvedilol on diastolic function in patients with diastolic heart failure andpreserved systolic function. Results of the Swedish Doppler-echocardiographic study(SWEDIC). . European Journal of Heart Failure . 2004; ;6: : 453– 461 .
    [Google Scholar]
  140. [140]. Palazzuoli   A   et al.   Left ventricular diastolic function improvement by carvedilol therapy inadvanced heart failure. . Journal of Cardiovascular Pharmacology . 2005; ;45: : 563– 568 .
    [Google Scholar]
  141. [141]. Cleland   JGF   et al.   The perindopril in elderly people with chronic heart failure (PEP-CHF) study. . European Heart Journal . 2006; ;27: : 2338– 2345 .
    [Google Scholar]
  142. [142]. Massie   BM   et al.   Irbesartan in patients with heart failure and preserved ejection fraction. . The NewEngland Journal of Medicine . 2008; ;359: : 2456– 2467 .
    [Google Scholar]
  143. [143]. McMurray   JJV   et al.   Heart failure with preserved ejection fraction: clinical characteristics of 4133patients enrolled in the I-PRESERVE trial. . European Journal of Heart Failure . 2008; ;10: : 149– 156 .
    [Google Scholar]
  144. [144]. The effect of digoxin on mortality and morbidity in patients with heart failure. TheDigitalis Investigation Group. The New England Journal of Medicine. 1997; 336,525–533.
  145. [145]. Schmidt   U   et al.   Restoration of diastolic function in senescent rat hearts through adenoviral genetransfer of sarcoplasmic reticulum Ca(2+)-ATPase. . Circulation . 2000; ;101: : 790– 796 .
    [Google Scholar]
  146. [146]. Jorgensen   K., , Bech-Hanssen   O., , Houltz   E., and Ricksten   S-E. Effects of Levosimendan on Left Ventricular Relaxation and Early Filling atMaintained Preload and Afterload Conditions After Aortic Valve Replacement forAortic Stenosis. . Circulation . 2008; ;117: : 1075– 1081 .
    [Google Scholar]
  147. [147]. Daniel   KR., , Wells   G., , Stewart   K., , Moore   B., and Kitzman   DW. Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function,and quality of life in older women with diastolic heart failure. . Congestive heartfailure (Greenwich, Conn.) . 15: : 68– 74 .
    [Google Scholar]
  148. [148]. Desai   AS   et al.   Rationale and design of the treatment of preserved cardiac function heart failure withan aldosterone antagonist trial: a randomized, controlled study of spironolactone inpatients with symptomatic heart failure and preserved ejection fraction. . AmericanHeart Journal . 2011; ;162: : 966-972.e10 .
    [Google Scholar]
  149. [149]. Little   WC   et al.   The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in thetreatment of elderly patients with diastolic heart failure. . Journal of Cardiac Failure . 2005; ;11: : 191– 195 .
    [Google Scholar]
  150. [150]. Busseuil   D   et al.   Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis. . Cardiology . 2010; ;117: : 234– 242 .
    [Google Scholar]
  151. [151]. De Masi De Luca   G. Ivabradine and Diastolic Heart Failure. . Journal of the American College ofCardiology . 2012; ;59: : E1009 .
    [Google Scholar]
  152. [152]. Kaye   D.M.., and Krum   H.. Drug discovery for heart failure: a new era or the end of the pipeline?. . NatureReviews. Drug Discovery . 2007; ;6: : 127– 139 .
    [Google Scholar]
  153. [153]. Kuwahara   F   et al.   Transforming growth factor-beta function blocking prevents myocardial fibrosis anddiastolic dysfunction in pressure-overloaded rats. . Circulation . 2002; ;106: : 130– 135 .
    [Google Scholar]
  154. [154]. Zeisberg   EM   et al.   Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. . NatureMedicine . 2007; ;13: : 952– 961 .
    [Google Scholar]
  155. [155]. Towbin JA. Clinical implications of basic research Scarring in the Heart — AReversible Phenomenon?? 1767–1768 (2007).
  156. [156]. McKinsey   TA. Targeting inflammation in heart failurewith histone deacetylase inhibitors. . Molecular medicine (Cambridge, Mass.) . 2011; ;17: : 434– 441 .
    [Google Scholar]
  157. [157]. Oka   T   et al.   Mitochondrial DNA that escapes from autophagy causes inflammation and heartfailure. . Nature . 2012; ;485: : 251– 255 .
    [Google Scholar]
  158. [158]. Kjekshus   J   et al.   Rosuvastatin in older patients with systolic heart failure. . The New England Journalof Medicine . 2007; ;357: : 2248– 2261 .
    [Google Scholar]
  159. [159]. Fukuta   H., , Sane   DC., , Brucks   S., and Little   WC. Statin therapy may be associated with lower mortality in patients withdiastolic heart failure: a preliminary report. . Circulation . 2005; ;112: : 357– 363 .
    [Google Scholar]
  160. [160]. Vlachopoulos   C., , Hirata   K., and O’Rourke   MF. Effect of sildenafil on arterial stiffness and wave reflection. . Vascular medicine(London, England) . 2003; ;8: : 243– 248 .
    [Google Scholar]
  161. [161]. Katz   SD   et al.   Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediatedvasodilation in patients with chronic heart failure. . Journal of the American College ofCardiology . 2000; ;36: : 845– 851 .
    [Google Scholar]
  162. [162]. Lewis   GD   et al.   Sildenafil improves exercise hemodynamics and oxygen uptake in patients withsystolic heart failure. . Circulation . 2007; ;115: : 59– 66 .
    [Google Scholar]
  163. [163]. Guazzi   M., , Vicenzi   M., , Arena   R., and Guazzi   MD. Pulmonary hypertension in heart failure with preserved ejection fraction: a target ofphosphodiesterase-5 inhibition in a 1-year study. . Circulation . 2011; ;124: : 164– 174 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2012.10
Loading
/content/journals/10.5339/gcsp.2012.10
Loading

Data & Media loading...

Supplementary File 1

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error